Franklin Galef
Internal Medicine · Vista, CANPI 1164439667
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AstraZeneca at 27.7% of the total. Reporting peaked in 2019 at $892 and has fallen 81.6% since, to $165 in 2025.
Across 162 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$863
- Pfizer$602
- GSK$350
- Boston Scientific$219
- Johnson & Johnson$174
- Novo Nordisk$110
- plus $800 from 23 others
What the payments were for
- Food & beverage$3,118100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 39 | $863 |
| Pfizer | 39 | $602 |
| GSK | 15 | $350 |
| Boston Scientific | 7 | $219 |
| Johnson & Johnson | 11 | $174 |
| Novo Nordisk | 6 | $110 |
| Eisai Inc. | 5 | $89 |
| Sanofi-aventis U.S. LLC | 4 | $69 |
| Mannkind Corporation | 4 | $63 |
| Antares Pharma, Inc. | 3 | $56 |
| Boehringer Ingelheim | 2 | $47 |
| Amgen | 3 | $45 |
| Amarin Pharma, Inc. | 2 | $41 |
| Merck | 2 | $40 |
| Aytu Biopharma, Inc. | 2 | $39 |
| Abbott | 2 | $34 |
| Organon | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Bayer | 1 | $26 |
| Philips North America LLC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Electromed, Inc. | 1 | $19 |
| Radius Health, Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| VBI Vaccine (delaware) Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $15 |
| Lilly USA, LLC | 1 | $13 |
| Astellas Pharma US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$266
How this compares
$3,118 in reported general payments places this provider in the 85th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Vista
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Hatim HusainSan Diego$2M
- Teck LingPalo Alto$1.1M
- Hyong Kimla Jolla$1M
- Rohit Loombala Jolla$965K
- Fred CohenSan Francisco$929K
- Steven EdelmanSan Diego$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.